METHOD OF ESTIMATING CLINICAL EFFICIENCY OF INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME IN PATIENTS SUFFERING FROM DILATATION CARDIOMYOPATHY WITH SECOND DEGREE OF CIRCULATORY DEFICIENCY WITHOUT ACCOMPANYING DISEASES AND INITIAL HYPOTENSIVE REACTIONS

摘要

FIELD: cardiology. SUBSTANCE: method may be used to estimate efficiency of preparations of inhibitors of angiotensin-converting enzyme in patients suffering from dilatation cardiomyopathy. In blood serum of patients, circulating immune complexes and complex/inhibitor ratios are determined in the beginning and after two-weak course of treatment with average-therapeutic doses of inhibitor. When level of circulating immune complexes drops more than by 30% as compared to its initial level, clinical efficiency of inhibitor is regarded as marked. EFFECT: enabled estimation of efficiency of treatment with inhibitors without veloergometric testing.